- Additional Authors
- Uniform Title
- Online access: NCBI NCBI Bookshelf.
- Subject
- Genre/Form
- Technical reports
- Technical reports.
- Note
- "Evidence-based synthesis program."
- "April 2012."
- Bibliography (note)
- Includes bibliographical references.
- Funding (note)
- Prepared for: Department of Veterans Affairs, Veterans Health Administration, Quality Enhancement Research Initiative, Health Services Research & Development Service, Washington, DC 20420. Prepared by: Evidence-based Synthesis Program (ESP) Center, Durham Veterans Affairs Healthcare System, Durham, NC, John W. Williams Jr., M.D., M.H. Sc., Director.
- VA-ESP
- Source of Description (note)
- Description based on online resource; title from PDF cover (VA, viewed April 22, 2021).
- Call Number
- GPO Internet VA 1.107/3:W 23
- OCLC
- 806430496
- Author
Adam, Soheir S., author.
- Title
Comparative effectiveness of warfarin and newer oral anticoagulants for the long-term prevention and treatment of arterial and venous thromboembolism / prepared for, Department of Veterans Affairs, Veterans Health Administration, Quality Enhancement Research Initiative, Health Services Research & Development Service ; prepared by, Evidence-based Synthesis Program (ESP) Center, Durham Veterans Affairs Healthcare System ; investigators, Soheir S. Adam [and others].
- Publisher
Washington, DC : Department of Veterans Affairs, Veterans Health Administration, Quality Enhancement Research Initiative, Health Services Research & Development Service, 2012.
- Description
1 online resource (iv, 115 pages) : illustrations (some color)
- Type of Content
text
- Type of Medium
computer
- Type of Carrier
online resource
- Series
Online access: NCBI NCBI Bookshelf.
- Bibliography
Includes bibliographical references.
- Summary
The Veterans Health Administration (VHA) System serves a largely older, male population with a high prevalence of chronic atrial fibrillation (AF) and venous thromboembolism (VTE). Many veterans with chronic AF have risk profiles for stroke that, according to current clinical guidelines, place them in a risk group where chronic anticoagulation is recommended. Adjusted-dose warfarin has been the preferred approach to chronic anticoagulation in the VHA, and in many VHA settings, specialized therapeutic drug-monitoring services provide high-quality warfarin treatment. However, the advent of newer anticoagulants with the promise of simplified long-term anticoagulation requires reconsideration of current treatment practices. The purpose of this systematic review was to study the comparative effectiveness of warfarin and the newer oral anticoagulants used for the long-term prevention and treatment of arterial and venous thromboembolism. An evaluation of newer oral anticoagulants for VTE prophylaxis in the perioperative period will be the subject of a later report.
- Funding
Prepared for: Department of Veterans Affairs, Veterans Health Administration, Quality Enhancement Research Initiative, Health Services Research & Development Service, Washington, DC 20420. Prepared by: Evidence-based Synthesis Program (ESP) Center, Durham Veterans Affairs Healthcare System, Durham, NC, John W. Williams Jr., M.D., M.H. Sc., Director.
VA-ESP 09-010
- Connect to:
- Added Author
United States. Department of Veterans Affairs. Health Services Research and Development Service, issuing body.
Durham VA Medical Center. Evidence-based Synthesis Program Center.
Quality Enhancement Research Initiative (U.S.)
Evidence-based Synthesis Program (U.S.)
- Gpo Item No.
0985-A-12 (online)
- Sudoc No.
VA 1.107/3:W 23
- Research Call Number
GPO Internet VA 1.107/3:W 23